http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003261520-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f6d9d1cf0da012c2cab50cf83992ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a7671b3d4dd360b5bbd6a4f08b6b416
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-34
filingDate 2002-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16cdcfa060466aa23ff7c007b91bc855
publicationDate 2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003261520-A
titleOfInvention Optical resolution method and method for producing optically active compound
abstract (57) [Problem] To provide an optical resolution method capable of easily and efficiently separating one enantiomer from an enantiomeric mixture. SOLUTION: The optical resolution method of the present invention comprises subjecting a solution containing a compound (A) having chirality capable of spontaneous preferential crystallization and an enantiomeric mixture of a compound to be resolved (B) to a crystallization operation, Along with the crystallization of the compound (A), one enantiomer of the compound to be resolved (B) is preferentially crystallized. Compound (A) includes: For example, amino acids such as asparagine are included. Examples of the compound to be resolved (B) include a compound having at least one group selected from an amino group, a carboxyl group, a hydroxyl group, a mercapto group, a carbonyl group, and a thiocarbonyl group.
priorityDate 2002-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415979899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454984946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID501025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6267

Total number of triples: 36.